You are here

Clinical Trials: Lung Disease

Comment

Discuss

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, May 8, 2014 - 12:00
Condition:   Idiopathic Pulmonary Fibrosis
Interventions:   Biological: Autologous Stromal Vascular Fraction (SVF);   Biological: Autologous Adipose Derived MSCs (ADMSCs);   Other: Control
Sponsor:   Kasiak Research Pvt. Ltd.
Recruiting - verified May 2014
Posted: Sunday, March 30, 2014 - 12:00
Condition:   Respiratory Distress Syndrome, Adult
Intervention:   Biological: Mesenchymal Stem Cell
Sponsor:   Asan Medical Center
Recruiting - verified January 2016
Posted: Wednesday, March 19, 2014 - 12:00
Condition:   Respiratory Distress Syndrome, Adult
Interventions:   Biological: Allogeneic Bone Marrow-Derived Human Mesenchymal Stem Cells;   Biological: Plasma-Lyte A
Sponsors:   Michael A. Matthay;   National Heart, Lung, and Blood Institute (NHLBI);   Massachusetts General Hospital;   Stanford University;   University of Pittsburgh;   University of Minnesota - Clinical and Translational Science Institute;   Ohio State University
Recruiting - verified December 2015
Posted: Sunday, March 16, 2014 - 12:00
Conditions:   Acute Lung Injury;   Acute Respiratory Distress Syndrome (ARDS);   Multiple Organ Failure
Intervention:   Drug: Menstrual blood stem cells
Sponsors:   S-Evans Biosciences Co.,Ltd.;   First Affiliated Hospital of Zhejiang University
Recruiting - verified March 2014
Posted: Friday, January 17, 2014 - 12:00
Condition:   Chronic Obstructive Pulmonary Disease
Intervention:   Other: Adipose Derived Stem Cells
Sponsor:   Bioheart, Inc.
Recruiting - verified April 2016
Posted: Friday, December 20, 2013 - 12:00
Condition:   Hepatopulmonary Syndrome
Interventions:   Drug: Sorafenib;   Drug: Placebo
Sponsors:   University of Pennsylvania;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified April 2016
Posted: Thursday, August 1, 2013 - 12:00
Condition:   Idiopathic Pulmonary Fibrosis
Interventions:   Biological: Endobronchial infusion of adult mesenchymal stem cells;   Biological: Autologous mesenchymal stem cells derived from bone marrow
Sponsor:   Clinica Universidad de Navarra, Universidad de Navarra
Recruiting - verified December 2015
Posted: Monday, July 29, 2013 - 12:00
Conditions:   COPD;   Cystic Fibrosis;   Pulmonary Fibrosis
Intervention:   Drug: Plerixafor mobilization of autologous CD117 stem cells
Sponsors:   University of Colorado, Denver;   Sanofi
Recruiting - verified January 2016
Posted: Sunday, July 14, 2013 - 12:00
Condition:   ARDS
Interventions:   Drug: Mesenchymal stem cells;   Drug: Placebo
Sponsor:   Shaoxing Second Hospital
Recruiting - verified July 2013
Posted: Thursday, July 4, 2013 - 12:00
Condition:   Bronchopulmonary Dysplasia
Interventions:   Biological: Pneumostem®;   Biological: normal saline
Sponsor:   Medipost Co Ltd.
Recruiting - verified January 2016

Pages